News in English
As recently as April, Novo Nordisk announced that Wegovy would be made available through the Hims & Hers telehealth platform. However, the decision to terminate the partnership just over a month later stems from concerns that the company has been distributing illegitimate versions of Wegovy. According to the Danish pharmaceutical giant, Hims & Hers has also engaged in misleading marketing practices that could compromise patient safety.
Novo Nordisk cuts ties with Hims & Hers after Wegovy dispute
Novo Nordisk is ending its collaboration with Hims & Hers Health due to concerns about the company’s sales and marketing practices related to the weight-loss drug Wegovy.
Av Ella Käck